openPR Logo
Press release

Anemia Drugs Market 2018 Grow at CAGR of 8.4% to Reach USD 34.7 Billion | By Unique Anemia Type Iron Deficiency Anemia, Sickle Cell Anemia and More

08-22-2018 01:31 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

Anemia Drugs Market

Anemia Drugs Market

Market Research Future Published a Prime research Report on “Global Anemia Drugs Market Research Report - Forecast to 2022” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2022

Global Anemia Drugs Market - Segments

Global anemia drugs market has been segmented on the basis of anemia type which comprises iron deficiency anemia, sickle cell anemia, aplastic anemia, hemolytic anemia pernicious anemia and others. On the basis of route of administration; market is segmented into oral and injectable. On the basis of gender; market is segmented into male and female. On the basis of product type; market is segmented into biologics and non-biologics. On the basis of end users; market is segmented into hospitals, self-administered and others.

Premium Sample Report Available @ https://www.marketresearchfuture.com/sample_request/2499

Global Anemia Drugs Market - Market Scenario

Anemia is a set of conditions characterized by weakness, shortness of breath and a general tiredness due to a decrease in the total amount of red blood cells (RBCs) or hemoglobin in the blood. The lowered hemoglobin results in a lowered ability of the blood to carry oxygen.

The market constraints are poor absorption of drugs especially intravenous iron and the side effects associated with the treatment. Better nutrition due to rising per capita income is also a market limiting factor for anemic drugs.

The global market for Anemia Drugs is expected to be around US$21.4 billion and is expected to grow at a CAGR of 8.4% to reach US$34.7 billion by the end of forecast period.

Global Anemia Drugs Market - Key Players

Some of the key players in this market are: Amgen Inc., GlaxoSmithKline plc, Bluebird bio, Biocon, GlycoMimetics Inc., Regen biopharma Inc., Bayer AG, Acceleron Pharma, Eli Lilly and company and others.

Global Anemia Drugs Market - Competitive Analysis

In April-2017, Amgen Inc. expanded their commercial collaboration with Novartis for erenumab, which is being investigated for the prevention of migraine. This expanded commercial collaboration was built on a global neuroscience collaboration in Alzheimer's disease and migraine established in 2015 between Novartis and Amgen. This expanded collaboration leveraged Novartis' strong and established presence in neuroscience to more effectively reach people with migraine.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/anemia-drugs-market-2499 

In December-2015, GlaxoSmithKline plc. announced that its global HIV business, ViiV Healthcare, has reached two separate agreements with Bristol-Myers Squibb, to acquire its late-stage HIV R&D assets; and to acquire Bristol-Myers Squibb’s portfolio of preclinical and discovery stage HIV research assets.

In October-2016, Elanco U.S., Inc., a subsidiary of Eli Lilly and Company acquired Boehringer Ingelheim Vetmedica, Inc.'s (BIVI) U.S. feline, canine and rabies vaccines portfolio - as well as a fully integrated manufacturing and R&D site - for USD 885 million, including the estimated cost of acquired inventory.

Global Anemia Drugs Market - Regional Analysis

On the regional backgrounds the Americas leads the global market for anemia drugs owing to huge patient population, increasing healthcare expenditures and presence of the developed economies like U.S. and Canada within the region. Following, the same trends Europe is second in the market. The Asia Pacific region is the fastest growing region due to the developing economies like India and China. Middle East and Africa have the least market share, especially due to the presence of poor economies within the African region. Moreover, stringent government policies within the region are restraining the market growth within the region. On the hand, Middle East leads the regional market due to the presence of developed economies like Kuwait, Qatar, and others within the region and rising healthcare expenses.

Table Of Contents

1 Introduction

2 Research Methodology

3 Market Dynamics

4 Market Factor Analysis

5 Global Anemia Drugs Market, By Anemia Type

6 Global Anemia Drugs Market, By Route Of Administration

7 Global Anemia Drugs Market, By Product Type

8 Global Anemia Drugs Market, By End User

9 Global Anemia Drugs Market, By Regions

10 Company Landscape

11 Company Profile

12 Others

13 Appendix

Major TOC Continued…!

Get Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/2499

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anemia Drugs Market 2018 Grow at CAGR of 8.4% to Reach USD 34.7 Billion | By Unique Anemia Type Iron Deficiency Anemia, Sickle Cell Anemia and More here

News-ID: 1194016 • Views:

More Releases from Market Research Future

Gigabit Internet Market 2024-2032: Comprehensive Growth Analysis, USD 57.8 Billion Opportunity
Gigabit Internet Market 2024-2032: Comprehensive Growth Analysis, USD 57.8 Billi …
✿➤ Market Overview The Gigabit Internet Market Industry is expected to grow from USD 15.63 Billion in 2024 to USD 57.8 Billion by 2032. The Gigabit Internet Market CAGR growth rate is expected to be around 17.76% during the forecast period 2024 - 2032. Gigabit Internet refers to broadband internet service that provides speeds of 1 gigabit per second (Gbps) or higher, enabling faster downloads, uploads, and smoother streaming experiences. It supports
Pigment Black Market to Witness Robust Expansion by 2032
Pigment Black Market to Witness Robust Expansion by 2032
The pigment black market encompasses a range of black pigments used across various industries, including automotive, construction, plastics, and coatings. These pigments are essential for providing deep black coloration and enhancing the visual appeal and performance of products. The market is characterized by a variety of black pigments, including carbon black, iron oxide black, and others, each with distinct properties and applications. Overview of Pigment Black Market Pigment Black Market Size was
Vegetable Fatty Acids Market Global Industry Report, 2032
Vegetable Fatty Acids Market Global Industry Report, 2032
The vegetable fatty acids market has been experiencing notable growth, driven by increasing consumer demand for natural and sustainable products. These fatty acids, derived from various vegetable sources such as palm oil, soybean oil, coconut oil, and sunflower oil, are essential ingredients in numerous industrial applications. Their versatility and biodegradability make them attractive alternatives to synthetic chemicals, aligning with the global trend towards sustainability and environmentally friendly products. Vegetable Fatty Acids
Pigment Red 166 Market to Reach $2.5 Billion, Globally, by 2032
Pigment Red 166 Market to Reach $2.5 Billion, Globally, by 2032
The global market for Pigment Red 166 (PR 166), a high-performance pigment known for its excellent lightfastness, heat resistance, and color strength, is experiencing robust growth. PR 166 is widely used in various applications, including plastics, coatings, inks, and textiles, due to its vibrant red hue and superior properties. This pigment is part of the azo pigment group and is valued for its stability and versatility, making it a preferred

All 5 Releases


More Releases for Anemia

Global Acquired Aplastic Anemia Market Insights, Forecast
Acquired aplastic anemia is a rare, serious blood disorder, due to failure of the bone marrow failure to produce blood cells. Bone marrow is the spongy substance found in the center of the bones of the body, in adults mainly the spine, pelvis, and large bones of the legs. The global Acquired Aplastic Anemia market is valued at xx million US$ in 2018 and will reach xx million US$ by
Anemia Drugs Market Increasing Awareness of Anemia & Anticipated To Create New O …
MarketResearchReports.Biz is providing you Retail Market Research report of "Anemia Drugs Market - Global Industry Trend Analysis 2012 to 2017 and Forecast 2017 - 2025". Anemia is a common cause of qualitative or quantitative deficiency of hemoglobin. Hemoglobin is an iron rich protein that caries the oxygen from lungs to the other parts of body tissue. The hemoglobin deficiency is generally associated with the decrease in the number of red blood
Global Anemia Drugs Market - Growth after 2017
This report studies the global Anemia Drugs market, analyzes and researches the Anemia Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like GlaxoSmithKline Global Blood Therapeutics (GBT) Bluebird Bio GlycoMimetics Mast Therapeutics Fibrogen Akebia Therapeutics Bayer AG Eli Lilly Regen Biopharma Acceleron Pharma Celgene Corporation Onconova Therapeutics Pieris Pharmaceuticals Market segment by Regions/Countries, this report covers United States EU Japan China India Southeast Asia To Get Sample Copy click here: https://www.qyresearchreports.com/sample/sample.php?rep_id=1336543&type=E List of Tables and Figures Figure
Anemia in Chronic Kidney Disease (Renal Anemia) - Industry Analysis, Trends, and …
Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Anemia in Chronic Kidney Disease Pipeline Review, H1 2017” to its report offerings. The report provides an overview of the Anemia in Chronic Kidney Disease (Renal Anemia) (Hematological Disorders) pipeline landscape. Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1196648 Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H1 2017,
Global Anemia in Chronic Kidney Disease (Renal Anemia) Clinical Trials Market Re …
Market Research Hub's clinical trial report, Global Anemia in Chronic Kidney Disease (Renal Anemia) Clinical Trials Review, H1, 2017, provides an overview of Anemia in Chronic Kidney Disease (Renal Anemia) clinical trials scenario. This report provides top line data relating to the clinical trials on Anemia in Chronic Kidney Disease (Renal Anemia). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Request
Current research on Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline R …
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anemia in Chronic Kidney Disease Pipeline Review, H2 2016, provides an overview of the Anemia in Chronic Kidney Disease (Hematological Disorders) pipeline landscape. Renal anemia is a disease in which the patient has an unusually low count of red blood cells. Renal is a term that means of the kidneys, so anemia is often associated with kidney disease. This type of